Mould DR - Search Results

1

Romiplostim dose response in patients with immune thrombocytopenia.

Perez-Ruixo JJ, Green B, Doshi S, Wang YM, Mould DR. Perez-Ruixo JJ, et al. Among authors: mould dr. J Clin Pharmacol. 2012 Oct;52(10):1540-51. doi: 10.1177/0091270011420843. Epub 2011 Dec 13. J Clin Pharmacol. 2012. PMID: 22167563 Clinical Trial.

2

Early Infliximab Clearance Predicts Remission in Children with Crohn's Disease.

Chung A, Carroll M, Almeida P, Petrova A, Isaac D, Mould D, Wine E, Huynh H. Chung A, et al. Dig Dis Sci. 2023 May;68(5):1995-2005. doi: 10.1007/s10620-022-07783-3. Epub 2022 Dec 23. Dig Dis Sci. 2023. PMID: 36562887

3

Pharmacokinetics of sapropterin in patients with phenylketonuria.

Feillet F, Clarke L, Meli C, Lipson M, Morris AA, Harmatz P, Mould DR, Green B, Dorenbaum A, Giovannini M, Foehr E; Sapropterin Research Group. Feillet F, et al. Among authors: mould dr. Clin Pharmacokinet. 2008;47(12):817-25. doi: 10.2165/0003088-200847120-00006. Clin Pharmacokinet. 2008. PMID: 19026037 Clinical Trial.

4

Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development.

Mould DR, Green B. Mould DR, et al. BioDrugs. 2010 Feb 1;24(1):23-39. doi: 10.2165/11530560-000000000-00000. BioDrugs. 2010. PMID: 20055530 Review.

5

Romiplostim dose-response in patients with myelodysplastic syndromes.

Perez Ruixo JJ, Doshi S, Wang YM, Mould DR. Perez Ruixo JJ, et al. Among authors: mould dr. Br J Clin Pharmacol. 2013 Jun;75(6):1445-54. doi: 10.1111/bcp.12041. Br J Clin Pharmacol. 2013. PMID: 23171070 Free PMC article.

6

Assessment of hemoglobin responsiveness to epoetin alfa in patients on hemodialysis using a population pharmacokinetic pharmacodynamic model.

Wu L, Mould DR, Perez Ruixo JJ, Doshi S. Wu L, et al. Among authors: mould dr. J Clin Pharmacol. 2015 Oct;55(10):1157-66. doi: 10.1002/jcph.527. Epub 2015 Jul 21. J Clin Pharmacol. 2015. PMID: 25907551 Clinical Trial.

7

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics.

Nguyen TH, Mouksassi MS, Holford N, Al-Huniti N, Freedman I, Hooker AC, John J, Karlsson MO, Mould DR, Pérez Ruixo JJ, Plan EL, Savic R, van Hasselt JG, Weber B, Zhou C, Comets E, Mentré F; Model Evaluation Group of the International Society of Pharmacometrics (ISoP) Best Practice Committee. Nguyen TH, et al. Among authors: mould dr. CPT Pharmacometrics Syst Pharmacol. 2017 Feb;6(2):87-109. doi: 10.1002/psp4.12161. Epub 2017 Feb 10. CPT Pharmacometrics Syst Pharmacol. 2017. PMID: 27884052 Free PMC article.

8

Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects.

Nieforth KA, Nadeau R, Patel IH, Mould D. Nieforth KA, et al. Clin Pharmacol Ther. 1996 Jun;59(6):636-46. doi: 10.1016/S0009-9236(96)90003-X. Clin Pharmacol Ther. 1996. PMID: 8681488 Clinical Trial.

9

Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response.

Mould DR, Baumann A, Kuhlmann J, Keating MJ, Weitman S, Hillmen P, Brettman LR, Reif S, Bonate PL. Mould DR, et al. Br J Clin Pharmacol. 2007 Sep;64(3):278-91. doi: 10.1111/j.1365-2125.2007.02914.x. Epub 2007 May 16. Br J Clin Pharmacol. 2007. PMID: 17506867 Free PMC article. Clinical Trial.

10

Modeling and simulation of abatacept exposure and interleukin-6 response in support of recommended doses for rheumatoid arthritis.

Roy A, Mould DR, Wang XF, Tay L, Raymond R, Pfister M. Roy A, et al. Among authors: mould dr. J Clin Pharmacol. 2007 Nov;47(11):1408-20. doi: 10.1177/0091270007307573. J Clin Pharmacol. 2007. PMID: 17962428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page